Anti-Cancer Agents in Medicinal Chemistry
Formerly: Current Medicinal Chemistry - Anti-Cancer Agents
Volume 19, 18 Issues, 2019
ISSN: 1875-5992 (Online)
ISSN: 1871-5206 (Print)
This journal supports open access
ISSN: 1875-5992 (Online)
ISSN: 1871-5206 (Print)
This journal supports open access
Ranking and Category
-
39th of 61 in
Chemistry, Medicinal
-
172nd of 229 in
Oncology
Open Access Articles
Nicotinamide Overcomes Doxorubicin Resistance of Breast Cancer Cells through Deregulating SIRT1/Akt Pathway
, 2019; 19(5): 687 - 696Yingze Wei, Yan Guo, Jianyun Zhou, Kui Dai, Qiang Xu and Xiaoxia Jin*
New Strategies for Therapeutic Cancer Vaccines
, 2019; 19(2): 213 - 221Hanjiao Qin, Jiyao Sheng, Dan Zhang, Xuewen Zhang, Linlin Liu*, Bingjin Li*, Guangquan Li* and Zhuo Zhang
Trichinella spiralis and Tumors: Cause, Coincidence or Treatment?
, 2018; 18(8): 1091 - 1099Chengshui Liao*, Xiangchao Cheng, Mingyuan Liu*, Xuelin Wang and Pascal Boireau
Astragalin Attenuates UVB Radiation-induced Actinic Keratosis Formation
, 2018; 18(7): 1001 - 1008Na Li, Kun Zhang, Xin Mu, Qiong Tian, Wenli Liu, Tianyuan Gao, Xiaona Ma* and Jian Zhang*
Regulation of Apoptosis by SYB in HepG2 Liver Cancer Cells is Mediated by the P53/Caspase 9 Axis
, 2017; 17(7): 941 - 947Sharula and Zhongjun Wu*
Epigenetic and miRNAs Dysregulation in Prostate Cancer: The role of Nutraceuticals
, 2016; 16(11): 1385 - 1402Alessandra Bosutti, Fabrizio Zanconati, Gabriele Grassi, Barbara Dapas, Sabina Passamonti and Bruna Scaggiante
Blood-Brain Barrier and Breast Cancer Resistance Protein: A Limit to the Therapy of CNS Tumors and Neurodegenerative Diseases
, 2016; 16(7): 810 - 815Anna Lisa Iorio, Martina da Ros, Ornella Fantappiè, Maurizio Lucchesi, Ludovica Facchini, Alessia Stival, Sabrina Becciani, Milena Guidi, Claudio Favre, Maurizio de Martino, Lorenzo Genitori and Iacopo Sardi
The Use of Anthracyclines for Therapy of CNS Tumors
, 2015; 15(6): 721 - 727Martina da Ros, Anna Lisa Iorio, Maurizio Lucchesi, Alessia Stival, Maurizio de Martino and Iacopo Sardi
Using Cytochalasins to Improve Current Chemotherapeutic Approaches
, 2015; 15(3): 327 - 335Matthew Trendowski
Synthesis, Preferentially Hypoxic Apoptosis and Anti-Angiogenic Activity of 3- Amino-1,2,4-Benzotriazine-1,4-Dioxide Bearing Alkyl Linkers with a 3-Amino-1,2,4- Benzotriazine-1-Oxide Moiety
, 2014; 14(10): 1428 - 1446Chun-I Lee, Chien-Ming Huang, Wen-Hsin Huang and An-Rong Lee
Episensitization: Therapeutic Tumor Resensitization by Epigenetic Agents: A Review and Reassessment
, 2014; 14(8): 1121 - 1127Bryan Oronsky, Neil Oronsky, Susan Knox, Gary Fanger and Jan Scicinski
Preclinical Development of Novel Rac1-GEF Signaling Inhibitors using a Rational Design Approach in Highly Aggressive Breast Cancer Cell Lines
, 2014; 14(6): 840 - 851Georgina A. Cardama, Maria J. Comin, Leandro Hornos, Nazareno Gonzalez, Lucas Defelipe, Adrian G. Turjanski, Daniel F. Alonso, Daniel E. Gomez and Pablo Lorenzano Menna
β2-Microglobulin-mediated Signaling as a Target for Cancer Therapy
, 2014; 14(3): 343 - 352Takeo Nomura, Wen-Chin Huang, Haiyen E. Zhau, Sajni Josson, Hiromitsu Mimata and Leland W. K. Chung
The Immunomodulation and Anti-Inflammatory Effects of Garlic Organosulfur Compounds in Cancer Chemoprevention
, 2014; 14(2): 233 - 240Georgia Schäfer and Catherine H. Kaschula
Cytotoxicity and Apoptosis Induced by a Plumbagin Derivative in Estrogen Positive MCF-7 Breast Cancer Cells
, 2014; 14(1): 170 - 180Sunil Sagar, Luke Esau, Basem Moosa, Niveen M. Khashab, Vladimir B. Bajic and Mandeep Kaur
Differential Effects of Polyphenols on Proliferation and Apoptosis in Human Myeloid and Lymphoid Leukemia Cell Lines
, 2013; 13(10): 1601 - 1613Amani A Mahbub, Christine L. Le Maitre, Sarah L. Haywood-Small, Gordon J. McDougall, Neil A. Cross and Nicola Jordan-Mahy
The Use of Lentinan for Treating Gastric Cancer
, 2013; 13(5): 681 - 688Kenji Ina, Takae Kataoka and Takafumi Ando
Redox-inactive Analogue of Tocotrienol as a Potential Anti-cancer Agent
, 2013; 13(3): 496 - 501Tomohiro Yano, Ayami Sato, Miki Sekine, Nantiga Virgona and Masako Ota
Are KRAS/BRAF Mutations Potent Prognostic and/or Predictive Biomarkers in Colorectal Cancers?
, 2012; 12(2): 163 - 171Tomoya Yokota
Cilengitide: The First Anti-Angiogenic Small Molecule Drug Candidate. Design, Synthesis and Clinical Evaluation
, 2010; 10(10): 753 - 768Carlos Mas-Moruno, Florian Rechenmacher and Horst Kessler
Pharmacogenomics of Human ABC Transporter ABCC11 (MRP8): Potential Risk of Breast Cancer and Chemotherapy Failure
, 2010; 10(8): 617 - 624Yu Toyoda and Toshihisa Ishikawa
New Medical Strategies for Midgut Carcinoids
, 2010; 10(3): 250 - 269Ola Nilsson, Yvonne Arvidsson, Viktor Johanson, Eva Forssell-Aronsson and Hakan Ahlman
Regulation of the Endoplasmic Reticulum Ca2+-Store in Cancer
, 2008; 8(7): 705 - 709A. Bergner and R. M. Huber
The Protein Kinase Inhibitor Balanol: Structure – Activity Relationships and Structure-Based Computational Studies
, 2008; 8(6): 638 - 645Vineet Pande, Maria J. Ramos and Federico Gago
Role of Mismatch Repair and MGMT in Response to Anticancer Therapies
, 2008; 8(4): 368 - 380Ida Casorelli, Maria Teresa Russo and Margherita Bignami
Inhibition of Protein Kinase c-Src as a Therapeutic Approach for Cancer and Bone Metastases
, 2008; 8(3): 342 - 349Nadia Rucci, Maria Susa and Anna Teti
  |
Editor-in-Chief
Michelle Prudhomme
Institut de Chimie de Clermont-Ferrand
ICCF-CNRS UMR 6296
Université Clermont Auvergne
Clermont-Ferrand
France
Biography
View Full Editorial Board
Institut de Chimie de Clermont-Ferrand
ICCF-CNRS UMR 6296
Université Clermont Auvergne
Clermont-Ferrand
France
Biography
Biography of Michelle Prudhomme
Prof. Michelle Prudhomme holds the position of Emeritus Professor at the Blaise Pascal University of Clermont-Ferrand, France. She was awarded Doctor-Engineer degree at the University of Caen France where her research focused on the synthesis of sulfur compounds. Then she received her Ph.D. Degree at the University of Clermont-Ferrand, France, after works on antibiotics. She developed projects related to drug design and discovery of cytotoxic compounds. She has authored or co-authored 108 research and review articles and and 6 patents.
Dr. Michelle Prudhomme was the founding Editor (2000) and is currently the Editor-in-Chief of this journal (Anti-Cancer Agents in Medicinal Chemistry), published by Bentham Science Publishers.
About the Journal
For Authors
For Librarians & Readers
Journal History
Current Medicinal Chemistry - Anti-Cancer Agents was launched in 2001 and later renamed in 2006 as Anti-Cancer Agents in Medicinal Chemistry.
Scopus CiteScore Metrics: 1.12
Highlighted Articles
Differential Effects of Antofine N-Oxide on Solid Tumor and Leukemia Cells, 2014: 14(10); 1315 - 1323
View Abstract Rights and Permissions
Differential Effects of Antofine N-Oxide on Solid Tumor and Leukemia Cells, 2014: 14(10); 1315 - 1323
Tania Bour, Xianwen Yang, Weihong Li, Francois Bernardin, Tony Kaoma, Arnaud Muller, Laurent Vallar and Andre Steinmetz.
View Abstract Rights and Permissions
Webmaster Contact: info@benthamscience.net